State Street Corp raised its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 11.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 508,266 shares of the medical instruments supplier’s stock after buying an additional 54,128 shares during the period. State Street Corp’s holdings in ICU Medical were worth $81,119,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of ICUI. AGF Investments LLC lifted its holdings in ICU Medical by 55.7% in the 2nd quarter. AGF Investments LLC now owns 1,476 shares of the medical instruments supplier’s stock valued at $372,000 after purchasing an additional 528 shares in the last quarter. Texas Permanent School Fund grew its holdings in shares of ICU Medical by 15.4% during the third quarter. Texas Permanent School Fund now owns 13,081 shares of the medical instruments supplier’s stock worth $2,088,000 after buying an additional 1,749 shares in the last quarter. Nuveen Asset Management LLC acquired a new stake in shares of ICU Medical in the second quarter valued at about $10,757,000. Findlay Park Partners LLP acquired a new stake in shares of ICU Medical in the second quarter valued at about $75,573,000. Finally, JPMorgan Chase & Co. lifted its stake in shares of ICU Medical by 4.2% in the second quarter. JPMorgan Chase & Co. now owns 539,633 shares of the medical instruments supplier’s stock worth $133,867,000 after buying an additional 21,930 shares in the last quarter. Institutional investors own 91.85% of the company’s stock.
In other ICU Medical news, Director Robert S. Swinney sold 373 shares of the business’s stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $153.49, for a total value of $57,251.77. Following the transaction, the director now directly owns 18,845 shares in the company, valued at approximately $2,892,519.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director George A. Lopez sold 20,000 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $184.29, for a total transaction of $3,685,800.00. Following the completion of the sale, the director now directly owns 368,864 shares of the company’s stock, valued at approximately $67,977,946.56. The disclosure for this sale can be found here. 11.40% of the stock is owned by insiders.
A number of equities analysts recently weighed in on the stock. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Thursday, November 21st. Zacks Investment Research downgraded shares of ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 14th. Raymond James raised their target price on shares of ICU Medical from $185.00 to $203.00 and gave the stock a “positive” rating in a research note on Tuesday, November 12th. TheStreet lowered ICU Medical from a “b-” rating to a “c+” rating in a research report on Monday, August 12th. Finally, ValuEngine lowered ICU Medical from a “buy” rating to a “hold” rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the stock. ICU Medical has a consensus rating of “Hold” and a consensus price target of $242.00.
Shares of ICUI opened at $179.16 on Tuesday. ICU Medical, Incorporated has a 52-week low of $148.89 and a 52-week high of $259.72. The company has a market capitalization of $3.83 billion, a PE ratio of 23.24 and a beta of 0.92. The stock has a fifty day simple moving average of $174.23 and a two-hundred day simple moving average of $195.73.
ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Monday, November 11th. The medical instruments supplier reported $1.65 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.03. ICU Medical had a net margin of 5.66% and a return on equity of 12.13%. The firm had revenue of $307.47 million for the quarter, compared to analysts’ expectations of $297.83 million. During the same quarter in the previous year, the company posted $1.85 EPS. The company’s revenue was down 6.0% compared to the same quarter last year. On average, equities analysts expect that ICU Medical, Incorporated will post 7.1 EPS for the current year.
ICU Medical Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
See Also: Should I invest in “strong buy” stocks?
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.